moderna

OpenCalais Metadata: Ticker

MRNA

OpenCalais Metadata: LegalName

MODERNA, INC.

Vučić announced: Meeting scheduled, main topic - urgent procurement of vaccines PHOTO

"Urgent procurement of vaccines is the only topic of today's meeting with representatives of the Institute of Virology, Vaccines and Serums 'Torlak', the Institute of Public Health of Serbia 'Dr Milan Jovanovic Batut', the Drug Agency and the RHIF," Vucic said, along with photos from the meeting on the official account of "Budunostsrbije" on Instagram.

EU reaches deal with Moderna on Covid-19 vaccine supply, says source

The European Union has reached a deal with US biotech firm Moderna for the supply of its Covid-19 vaccine candidate, an EU official told Reuters on Tuesday.

Last week Moderna said its experimental vaccine was 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.

WHO chief sees 'light at the end of long, dark tunnel'

With current vaccine developments, the light at the end of the COVID-19 tunnel is growing brighter, the World Health Organization (WHO) chief said on Nov. 23.

WHO Director-General Tedros Ghebreyesus gave an upbeat assessment on vaccine development after recent data showed that more COVID-19 cases had been reported in a recent 4 weeks than in first 6 months of the pandemic.

COVID-19 Vaccine: AstraZeneca and Oxford University Seek Approval after 'Effective' Trials

 

British drugs group AstraZeneca and the University of Oxford said on Monday they will seek regulatory approval for their coronavirus vaccine after "effective" trials, in the latest potential boost to curbing the global outbreak.

The partners announced that while the vaccine showed an average 70-percent effectiveness, the level jumped to 90 percent depending on dosage. 

Pages